| Predicate |
Object |
| contentType |
Journal Article|Review |
| endingPage |
66 |
| issn |
1179-2027
1170-7690 |
| issueIdentifier |
1 |
| pageRange |
40-66 |
| publicationName |
PharmacoEconomics |
| startingPage |
40 |
| bibliographicCitation |
Bryson HM, Plosker GL. Tamoxifen: a review of pharmacoeconomic and quality-of-life considerations for its use as adjuvant therapy in women with breast cancer. Pharmacoeconomics. 1993 Jul;4(1):40–66. doi: 10.2165/00019053-199304010-00006. PMID: 10146967. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8588bebd7f8d15d5154ba1b374e5279d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_55d922330f494735a86f11a6b7564911 |
| date |
199307 |
| identifier |
https://doi.org/10.2165/00019053-199304010-00006
https://pubmed.ncbi.nlm.nih.gov/10146967 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1179-2027
https://portal.issn.org/resource/ISSN/1170-7690
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21262 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/ |
| title |
Tamoxifen: a review of pharmacoeconomic and quality-of-life considerations for its use as adjuvant therapy in women with breast cancer |
| discusses |
http://id.nlm.nih.gov/mesh/M0007795
http://id.nlm.nih.gov/mesh/M0021024 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 |